Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Added Clinically reviewed

CASCADE: mechanisms, evidence & therapeutic decisions

CASCADE · Professional learning · English

See how a therapy works. Examine what the evidence supports. Bring both into a thoughtful clinical decision.

Authored by Olga Goodman, MD · Rheumatology in Perspective
Oral IL-23 receptor blockade · Reviewed 25 September 2026

Choose your starting point

Take the complete learning sequence or open the activity that fits your question. Each module retains its own visual language and interactive tools.

One pathway. Different clinical questions.

These activities distinguish molecular mechanism, plaque-psoriasis evidence and the assessment of suspected or established psoriatic arthritis. A shared signaling pathway does not establish a treatment indication.

Professional access

Sign in with your registered RheumaView account to open these clinical learning modules and keep your progress.

Sign in to continue

For healthcare professionals. Access requires an account and a professional declaration. Request professional access.

Read alongside the modules

Keep receptor-level mechanisms in context with intracellular signaling and disease-specific assessment.

JAK & TYK2 signaling →Spondyloarthritis collection →

Know what your result means

Knowledge results and engagement points serve different purposes. Learning milestones are personal records; these activities do not award CME credit.

Evidence, disclosures & review →

CASCADE · SLE learning series · English · For healthcare professionals

Daniela’s SLE journey: mechanism, decisions and follow-up

Explore three interactive modules on systemic lupus erythematosus (SLE), from treatment mechanisms to clinical reasoning and a year of follow-up.

Open access — no registration required. These three modules are temporarily available to everyone.

Open a module below to begin, or use its separate-tab link for more space. For an unprompted treatment-choice exercise, begin with module 2 before exploring the companion modules.

Module 1 of 3 · Interactive learning · CAS-SAPHNELO-SLE-001

Break the Loop: Type I Interferon Receptor Blockade in SLE

Explore type I interferon signaling, Saphnelo (anifrolumab), clinical evidence and patient selection through Daniela’s SLE case, a narrated mechanism film and interactive checks.

Topics: Cascade · Lupus · Anifrolumab · Type I interferon · Mechanism of action · Interactive learning

Open module 1: Break the Loop: Type I Interferon Receptor Blockade in SLE

Open the full module in a new tab ↗

Back to the SLE series

Module 2 of 3 · Interactive learning · CAS-SLE-002

Daniela: What Comes Next?

Work through a three-stage SLE clinical reasoning case: identify Daniela’s priorities, weigh the medical facts, and rank treatment options for lupus that remains active on standard therapy.

Topics: Cascade · Lupus · Interactive case · Clinical reasoning

Open module 2: Daniela: What Comes Next?

Open the full module in a new tab ↗

Back to the SLE series

Module 3 of 3 · Interactive learning · CAS-SAPHNELO-SLE-003

Daniela: The First 52 Weeks

Guide Daniela through a year of Saphnelo (anifrolumab) treatment in this SLE simulation. Make decisions about vaccination, infusion reactions, prednisone tapering, infections, home injections and follow-up, then review the illustrated course.

Topics: Cascade · Lupus · Anifrolumab · Interactive case · Medication safety

Open module 3: Daniela: The First 52 Weeks

Open the full module in a new tab ↗

Back to the SLE series

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: CascadeIL-23PsoriasisPsoriatic arthritis